Figure 1.
Kaplan-Meier estimate of survival probability for patients with mCRC treated with 1L bevacizumab-awwb who had no prior exposure to the RP.
1L, first-line; mCRC, metastatic colorectal cancer; RP, reference product.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.